You are viewing the site in preview mode
Skip to main content
|
Author
|
Year
|
Country
|
Total number of patients
|
Mean age
|
Clinical stage
|
Treatment
|
Number of patients with HPV-16 positive
|
Number of patients with HPV-18 positive
|
Median DFS
|
Median PFS
|
Median OS
|
|---|
|
Mi Chen
|
2019
|
China
|
131
|
29–61
|
I-III
|
adjuvant radiation
|
88
|
19
|
HR: 1.13, 95% CI = 0.78–1.64
|
NA
|
HR: 1.39, 95% CI = 1.14–1.69
|
|
Yuanyuan Wang
|
2018
|
China
|
232
|
NA
|
I-III
|
adjuvant radiation
|
108
|
19
|
NA
|
Not significant
|
HR: 2.17, 95% CI = 1.20–3.92
|
|
Ruihong Lan
|
2017
|
China
|
40
|
40.21
|
II-III
|
adjuvant radiation
|
22
|
10
|
NA
|
NA
|
HR: 1.15, 95% CI = 1.01–1.31
|
